PX1 Research provides USA-manufactured, lot-tested Tesamorelin and Ipamorelin research compounds synthesized strictly for laboratory evaluation. Each batch undergoes rigorous HPLC and mass spectrometry analysis to ensure chemical identity and purity standards exceeding 99% for qualified academic and industrial institutions.
PX1 Research provides USA-manufactured, lot-tested Tesamorelin and Ipamorelin research compounds synthesized strictly for laboratory evaluation. Each batch undergoes rigorous HPLC and mass spectrometry analysis to ensure chemical identity and purity standards exceeding 99% for qualified academic and industrial institutions.
Qualified laboratories seeking reliable tesamorelin & ipamorelin for sale require high-purity reference materials backed by comprehensive analytical data. When purchasing these growth hormone secretagogues for in vitro assays or preclinical animal models, researchers must verify that compounds are synthesized under strict quality controls to guarantee reproducible experimental outcomes.
Tesamorelin and Ipamorelin represent two distinct biochemical classes within the growth hormone secretagogue spectrum: a stabilized growth hormone-releasing hormone (GHRH) analogue and a selective growth hormone secretagogue receptor (GHSR-1a) agonist, respectively. Sourcing these reagents from PX1 Research ensures access to USA-manufactured peptides verified via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
Tesamorelin is a synthetic 44-amino acid peptide derivative of endogenous GHRH, modified with a trans-3-hexenoic acid group at the N-terminus. This structural alteration enhances resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4) in biological fluids. Upon binding to the GHRH receptor on pituitary somatotropes, tesamorelin stimulates the adenylate cyclase/cAMP pathway, prompting the synthesis and endogenous release of growth hormone.
Conversely, Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that selectively targets the ghrelin receptor (GHSR-1a). Unlike first-generation peptide secretagogues, ipamorelin's binding profile triggers intracellular calcium mobilization via the inositol trisphosphate (IP3) pathway without activating glucocorticoid or lactotrope pathways. Investigating both compounds within a single experimental framework allows investigators to explore dual-receptor agonism and potential synergism in growth hormone secretion dynamics.
For additional technical specifications on individual secretagogues, researchers can consult our dedicated tesamorelin reference guide and detailed ipamorelin peptide documentation.
A central focus of preclinical secretagogue research is achieving target hormone release while minimizing off-target neuroendocrine activation. In animal models, classical GH secretagogues frequently induce transient spikes in adrenocorticotropic hormone (ACTH), cortisol, and prolactin. Literature indicates that Ipamorelin exhibits exceptional receptor selectivity, failing to provoke significant cortisol or prolactin release even at elevated concentrations in rodent models.
Preclinical data evaluating GHRH analogues like Tesamorelin show that sustained receptor engagement supports physiological, pulsatile growth hormone release rather than continuous tonic elevation. This pulsatile pattern is critical in animal models evaluating somatotropic signaling, lipid metabolism, and hepatic insulin-like growth factor-1 (IGF-1) transcription.
Combined exposure in animal models suggests that dual administration of a GHRH agonist and a GHSR-1a agonist yields a supra-additive growth hormone response without compromising baseline endocrine homeostasis. Researchers can review our broader catalog of research peptides for complementary secretagogues utilized in comparative signaling assays.
Evaluating secretagogue combinations requires mapping their affinity profiles against traditional reference compounds. While Tesamorelin provides GHRH receptor stimulation, alternative GHRH analogues such as cjc-1295 no dac offer varying half-life profiles due to structural modifications that influence plasma protein binding. Similarly, sermorelin serves as a truncated 29-amino acid GHRH fragment widely utilized in baseline somatotropic research.
When assessing the ghrelin receptor pathway, Ipamorelin is frequently compared against ghrp-2 and hexarelin. While GHRP-2 and Hexarelin demonstrate robust GH release capabilities in vitro, they routinely induce measurable elevations in plasma cortisol and prolactin in preclinical trials. Ipamorelin remains the primary choice for investigators requiring absolute endocrine selectivity in non-human subjects.
When procurement departments search for tesamorelin & ipamorelin for sale, analytical verification remains the definitive benchmark for reagent quality. Inferior or unverified peptides introduce confounding variables into assay systems, such as truncated amino acid sequences, TFA salt carryover, and bacterial endotoxin contamination.
PX1 Research mandates strict lot-specific third-party testing for every production run. Each peptide container is supplied with an accessible Certificate of Analysis detailing:
1. Purity Assessment (RP-HPLC): Quantifies peptide purity, ensuring chemical homogeneity above 98-99% without residual synthetic side-products. 2. Molecular Weight Verification (ESI-MS): Confirms exact molecular mass against theoretical sequence weight. 3. Endotoxin Testing (LAL Assay): Verifies endotoxin levels remain below strictly controlled limits (<0.01 EU/mg) to prevent inflammatory responses in cell cultures or animal models. 4. Residual Solvent and Moisture Content: Guarantees dry lyophilized cake stability.
Researchers can review sample testing protocols and methodology in our peptide analytical testing hub.
Both Tesamorelin and Ipamorelin are supplied as sterile, lyophilized powders to maintain long-term peptide stability. For optimal activity in laboratory protocols, standard handling procedures must be observed by trained research personnel.
Reconstitution should occur in an aseptic laminar flow hood using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl), depending on assay compatibility. Reagents should be reconstituted by directing the liquid media against the glass vial wall rather than directly onto the lyophilized cake to prevent mechanical shear stress.
Gentle swirling is recommended until full dissolution is achieved; vortexing or high-energy agitation must be avoided as it can induce protein aggregation or peptide bond cleavage. Once reconstituted, solutions should be aliquoted into single-use polypropylene microtubes to avoid repeated freeze-thaw cycles and stored at -20°C to -80°C for extended stability.
Lyophilized research peptides display high thermal stability when stored under controlled environment conditions prior to reconstitution:
• Unopened Lyophilized Powder: Stable at 2°C to 8°C for short-term handling; long-term storage recommended at -20°C away from light and humidity. • Reconstituted Liquid Phase: Stable at 2°C to 8°C for up to 28 days when preserved with bacteriostatic agents. Unpreserved solutions for cell culture must be used immediately or frozen.
Adherence to these environmental parameters prevents peptide hydrolysis and methionine oxidation, protecting reagent integrity across multi-week experimental timelines.
The integrity of preclinical data depends on consistency across chemical lots. PX1 Research manufactures all research peptides in US-based, GMP-compliant facilities utilizing state-of-the-art solid-phase peptide synthesis (SPPS) equipment.
By maintaining dual distribution nodes in California and Arizona, PX1 eliminates international customs bottlenecks and cold-chain breakdown risks. Institutional procurement teams seeking continuous batch availability for large-scale studies can establish wholesale laboratory supply accounts to ensure dedicated lot reservation and rapid supply chain continuity.
What is the primary difference between Tesamorelin and Ipamorelin?
Tesamorelin is a synthetic 44-amino acid GHRH analogue that binds directly to GHRH receptors on somatotropes. Ipamorelin is a synthetic pentapeptide that acts as a selective agonist at the ghrelin/growth hormone secretagogue receptor (GHSR-1a). They target distinct receptor systems involved in somatotropic signaling.
Why are Tesamorelin and Ipamorelin studied together in research models?
In preclinical research, combining a GHRH receptor agonist with a GHSR-1a agonist evaluates potential receptor cross-talk and synergistic growth hormone release. Dual-pathway activation often triggers a greater physiological pulse than either compound administered individually.
Does Ipamorelin elevate cortisol or prolactin in research subjects?
Preclinical data demonstrate that Ipamorelin is highly selective for the GHSR-1a receptor and does not trigger statistically significant elevations in ACTH, cortisol, or prolactin, even at concentrations well above threshold secretagogue doses in animal models.
What purity levels are provided with PX1 Research peptides?
PX1 Research supplies Tesamorelin and Ipamorelin at purified levels exceeding 98% to 99%, as verified by lot-specific Reverse-Phase HPLC and ESI Mass Spectrometry analysis.
How are these compounds packaged for shipping?
Compounds are shipped as lyophilized (freeze-dried) powders in sealed vacuum vials. PX1 Research dispatches orders same-day (Monday through Friday) from CA and AZ facilities to minimize transit times and protect ambient stability.
Are these compounds suitable for human clinical administration?
No. All products sold by PX1 Research are strictly designated for laboratory research use only (in vitro and preclinical animal models). They are not intended for human consumption, therapeutic use, or clinical administration.
What reconstituting media should be used in animal or tissue culture assays?
Standard laboratory protocols typically utilize sterile Bacteriostatic Water for multi-dose animal research vials or sterile Phosphate-Buffered Saline (PBS, pH 7.4) for direct cell culture assays requiring non-toxic vehicle solutions.
How can I access the COA for a specific lot of Tesamorelin or Ipamorelin?
Certificates of Analysis featuring HPLC chromatograms and mass spectra are available directly on product documentation pages or upon request by providing the lot number printed on the vial label.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.